BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190718T143000
DTEND;TZID=America/New_York:20190718T154500
DTSTAMP:20190621T172956Z
CREATED:20190521T172808Z
LAST-MODIFIED:20190621T172956Z
UID:29335-1563460200-1563464700@globalbiodefense.com
SUMMARY:Managing Media Relations During a Public Health Emergency
DESCRIPTION:For the second year in a row\, NACCHO is pleased to host a multi-part webinar series to help local health departments build capacity to engage in public health communication. Coordinated by NACCHO and the National Public Health Information Coalition (NPHIC)\, “Managing Media Relations” will help participants learn basic media relations principles; understand what NOT to say; understand how to change the conversation to YOUR message; and where to look for help when things go wrong. \nLearning Objectives \n\nIntroduce basic principles of interacting with and pitching local media\nUnderstand different types of media communications tactics\, (e.g.\, press releases\, backgrounders\, media advisories and press briefings)\nLearn best practices for educating media partners on health topics/data to avoid inaccuracy\n\nFeatured Speakers \n\nRichard Sheehe\, Senior Strategist\, The Merritt Group & Senior Research Fellow\, George Washington University\nKristina Wieghmink\, M.Ed.\, Communication Specialist/Public Information Officer\, Ottawa County Dept. of Public Health\n\nThe webinar will be recorded for on-demand viewing. REGISTER TO JOIN.
URL:https://globalbiodefense.com/event/managing-media-relations-during-a-public-health-emergency/
LOCATION:Webinar
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190715
DTEND;VALUE=DATE:20190719
DTSTAMP:20240118T180211Z
CREATED:20190213T192233Z
LAST-MODIFIED:20240118T180211Z
UID:23490-1563148800-1563494399@globalbiodefense.com
SUMMARY:Summer Workshop on Pandemics\, Bioterrorism\, and Global Health Security: From Anthrax to Zika
DESCRIPTION:Threats to global health security continue to evolve due to the changing nature of conflict\, advances in science and technology\, globalization\, and the growing threat posed by emerging infectious diseases and pandemics. Pandemics\, Bioterrorism and Global Health Security: From Anthrax to Zika is a three-day\, non-credit summer workshop designed to introduce participants to the challenges facing the world at the intersection of national security\, public health\, and the life sciences. The workshop faculty are internationally recognized experts from the government\, private sector\, and academia who have been extensively involved with research and policy-making on public health\, biodefense\, and national security issues. \nThe workshop is organized by the Biodefense Graduate Program at the Schar School of Policy and Government and will be held at the Schar School’s campus in Arlington\, Virginia on July 15-18\, 2019. \nPrivate and public organizations face a number of challenges in adapting to the changing global biosecurity landscape. The spectrum of biological threats is diverse\, including naturally occurring disease outbreaks such as SARS\, Zika\, and Ebola\, lapses in biosafety\, dual-use research of concern\, and the threat of bioterrorism. A severe disease outbreak\, whether natural or man-made\, can affect not just public health\, but also public safety and national security. Pandemics and bioterrorist attacks will confront government agencies and the private sector with the need to make high-impact decisions with limited information during a rapidly evolving situation. Further complicating this domain is the dual-use nature of biology: the knowledge\, skills\, and technology developed for legitimate scientific and commercial purposes can be misused by those with hostile intent. Research with dangerous pathogens and the development of advanced biotechnologies such as synthetic biology and genome editing poses a dilemma for policy-makers and researchers who seek to maximize the benefits of such research while minimizing the risks. Thus\, public health\, law enforcement and national security agencies\, the pharmaceutical and biotech industries\, and the academic life sciences community need to develop new types of expertise\, adopt new types of risk assessment and risk management strategies\, and learn to collaborate with each other. \nImplementing these new priorities will require substantial organizational learning and change. But large organizations have deeply embedded professional norms and organizational culture that make them resistant to change\, even during times of crisis. Each organization responds with its own routines\, and its own distinctive view of “the threat\,” which dilutes new initiatives\, encourages stovepiping\, and impedes effective collaboration. These organizational tendencies grow even more pronounced during times of declining budgets. Thus\, while the need for collaboration is great\, the potential for differing organizational styles to produce conflict is high. \nThe 1976 swine flu scare\, 2001 anthrax letter attacks\, SARS and avian influenza outbreaks\, 2009 H1N1 influenza pandemic\, 2014-2016 Ebola outbreak in West Africa\, and 2015-2017 Zika outbreak provide rich case studies of how government agencies and international organizations have struggled to address novel biological threats\, make high-impact decisions with limited information\, and work effectively with new partners. The lessons from these cases are broadly applicable to both public and private organizations seeking to address current and emerging biosecurity risks. \nFeatures\n\nSyllabus and reading materials\nSocial hour after first day of course\nLight breakfast\, coffee\, and lunch provided on all days\nCertificate of Attendance\n\nCourses Objectives\n\nIdentify the range of biological threats and assess the risks they pose to public health and national security\nDescribe impediments to organizational change and identify strategies for overcoming these obstacles.\nExamine lessons learned from the SARS and avian flu outbreaks\, the 2009 influenza pandemic\, and the 2014-2016 West Africa Ebola outbreak.\nExplore the dual-use dilemma and how to balance the benefits of advanced biotechnologies against the safety and security risks they can pose.\nInvestigate the growing importance of biotechnology to the national economy\, domestic and international risks to biotechnology innovation\, and legal\, policy\, and regulatory measures for safeguarding the bioeconomy.\nUnderstand the technical\, political\, regulatory\, and financial obstacles to developing new medical countermeasures for bioterrorist and pandemic threats.\n\nWho Should Attend\nProfessionals and academics\, both domestic and international\, in public health\, the life sciences\, the biotechnology and pharmaceutical industries\, international affairs\, law enforcement\, emergency management\, and national security who have responsibilities for preventing\, preparing for\, or responding to pandemics\, bioterrorism\, and other threats to global health security. \nPast participants have come from a range of government agencies\, private and non-profit organizations\, and universities and think tanks including: \n\nDepartment of Health and Human Services\nNational Institutes of Health\nFood and Drug Administration\nBiomedical Advanced Research and Development Authority\nCenters for Disease Control and Prevention\nFederal Emergency Management Agency\nDepartment of Defense\nDefense Threat Reduction Agency\nLawrence Livermore National Laboratory\nPacific Northwest National Laboratory\nOak Ridge National Laboratory\nSandia National Laboratories\nCenter for Biosecurity and Biopreparedness in Denmark\nBiosecurity Office of the Netherlands\nRwanda Ministry of Agriculture\nPhilippine National Police Force\nNational Center for Disease Control and Public Health in Georgia\nDefence Research and Development Canada\nCRDF Global\nBattelle Memorial Institute\nEmergent BioSolutions\nBooz Allen Hamilton\nBAE Systems\nEngility\nNoblis\nQuest Diagnostics\nSynthetic Genomics\nSanofi\nBiotechnology Innovation Organization\nMerrick & Company\nVirginia Tech\nKent State University\nUniversity of South Florida\nInstitute for Defense Analysis\nMITRE\nUC Berkeley\nNational Defense University\nUniversity of Sussex\nSAIS\nGeorgetown University\nANSER\n\nRegistration\nPlease note that we will only be accepting payment by credit card for this event. \nPrior to May 1\, the course fee is $1\,200. After May 1\, the course fee is $1\,400. Discounts are available for George Mason University faculty\, students\, and alum and for groups of three or more from the same organization. If you qualify for one of these discounts or have any questions regarding registration\, please email biodefense@gmu.edu. \n*Cancellation Policy: Refunds will be available if cancelled prior to the start to the start of the workshop (July 15\, 2019). \nLogistics \nThe summer workshop will be held on July 15-18\, 2019 on the Arlington campus of the Schar School of Policy and Government. The Schar School is located in Founder’s Hall at 3351 Fairfax Drive in Arlington\, VA. The school is conveniently located two blocks from the Virginia Square-GMU Metro station on the Orange Line. Garage parking is also available. \nList of Instructors\nDavid R. Franz\, DVM\, PhD\, served in the U.S. Army Medical Research and Materiel Command for 23 of 27 years on active duty and retired as colonel. He served as commander of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and as deputy commander of the Medical Research and Materiel Command. Prior to joining the Command\, he served as group veterinarian for the 10th Special Forces Group (Airborne). His current standing committee appointments include the Department of Health and Human Services National Science Advisory Board for Biosecurity (NSABB)\, the National Academy of Sciences Committee on International Security and Arms Control\, the National Research Council Board on Life Sciences\, and the Senior Technical Advisory Committee of the National Biodefense Countermeasures Analysis Center. Dr. Franz was the chief inspector on three United Nations Special Commission biological warfare inspection missions to Iraq and served as technical advisor on long-term monitoring. He also served as a member of the first two US-UK teams that visited Russia in support of the Trilateral Joint Statement on Biological Weapons and as a member of the Trilateral Experts’ Committee for biological weapons negotiations. Dr. Franz was technical editor for the Textbook of Military Medicine on Medical Aspects of Chemical and Biological Warfare released in 1997. He serves as a Senior Mentor to the Program for Emerging Leaders at the National Defense University. He also serves on the Board of Integrated Nano-Technologies\, LLC. Dr. Franz holds an adjunct appointment as Professor for the department of Diagnostic Medicine and Pathobiology at the College of Veterinary Medicine\, Kansas State University. The current focus of his activities relates to the role of international engagement in the life sciences as a component of national security policy. Dr. Franz holds a DVM from Kansas State University and a PhD in physiology from Baylor College of Medicine. \nGregory D. Koblentz\, PhD\, MPP\, is an Associate Professor in the Schar School of Policy and Government and Director of the Biodefense Graduate Program at George Mason University. During 2012-2013\, he was a Stanton Nuclear Security Fellow at the Council on Foreign Relations. Dr. Koblentz is also a member of the Scientist Working Group on Chemical and Biological Weapons at the Center for Arms Control and Non-Proliferation in Washington. He previously worked at Georgetown University\, the Executive Session for Domestic Preparedness at Harvard University\, and the Carnegie Endowment for International Peace. He is the author of Strategic Stability in the Second Nuclear Age (Council on Foreign Relations\, 2014)\, Living Weapons: Biological Warfare and International Security (Cornell University Press\, 2009) and co-author of Tracking Nuclear Proliferation (Carnegie Endowment for International Peace\, 1998). He serves on the editorial boards of Nonproliferation Review\, World Medical and Health Policy\, and Global Health Governance. His teaching and research interests focus on international security\, weapons of mass destruction\, terrorism\, and homeland security. He received his PhD from the Massachusetts Institute of Technology\, his Master in Public Policy from the John F. Kennedy School of Government\, and his BA from Brown University. For more information\, see https://schar.gmu.edu/about/faculty-directory/gregory-koblentz \nJens H. Kuhn\, MD\, PhD\, PhD\, MS\, is a Research Leader at Battelle Memorial Institute\, Columbus\, OH\, USA\, tasked as the Virology Lead (Contractor) at NIH/NIAID/DCR’s Biosafety Level 4 facility\, the Integrated Research Facility at Fort Detrick (IRF-Frederick) in Frederick\, MD\, USA. Dr. Kuhn specializes in highly virulent viral human and animal pathogens. He is the author of “Filoviruses: A Compendium of 40 Years of Epidemiological\, Clinical\, and Laboratory Studies” (Vienna: Springer\, 2008) and co-author of “The Soviet Biological Weapons Program—A History” (Cambridge: Harvard University Press\, 2012)\, and has studied and worked in Germany\, Italy\, Malta\, Russia\, South Africa\, and South Korea. In the US\, he rotated through or worked at Harvard Medical School\, Boston\, MA; the Arthropod-borne Infectious Disease Laboratory (AIDL) in Fort Collins\, CO; the Centers for Disease Control and Prevention (CDC) in Atlanta\, GA; and the US Army Medical Research Institute of Infectious Diseases (USAMRIID) in Frederick\, MD. Dr. Kuhn was the first western scientist with permission to work in a former Soviet biological warfare facility\, SRCVB “Vektor” in Siberia\, Russia\, within the US Department of Defense’s Cooperative Threat Reduction (CTR) Program. Dr. Kuhn was a contributor to the Center for International and Security Studies at Maryland’s Controlling Dangerous Pathogens Project and a member of the Center for Arms Control and Nonproliferation’s CBW Scientist Working Group. He is currently a Subcommittee Chair and Member of the Executive Committee of the International Committee on Taxonomy of Viruses (ICTV)\, Chair of the ICTV Bunyavirales and Filoviridae Study Groups\, and a member of the ICTV Arenaviridae\, Bornaviridae\, Nairoviridae\, and Nyamiviridae Study Groups. He furthermore serves as a Subject Matter Expert for NCBI for all mononegaviruses as a member of the NCBI Genome Annotation Virus Working Group and the database RefSeq. Dr. Kuhn is a member of the editorial boards of 10 journals\, and has been a peer reviewer for more than 60 journals\, including Cell\, Cell Host & Microbe\, Emerging Infectious Diseases\, JAMA\, The Lancet. Infectious Diseases\, Nature\, Nature Microbiology\, Nature Protocols\, PLoS Pathogens\, Science\, and Journal of Virology. Dr. Kuhn also was a member of the 2009-2011 US National Academy of Sciences’ Committee on “Animal Models for Assessing Countermeasures to Bioterrorism Agents”; and was part of several AAAS and US State Department bioengagement efforts in the BMENA Region\, Turkey\, and the NIS countries. Dr. Kuhn can be found on LinkedIn at http://www.linkedin.com/pub/jens-h-kuhn/1b/817/72 and on ResearchGate at https://www.researchgate.net/profile/Jens_Kuhn. \nSanford L. Weiner is a Research Associate in the Center for International Studies at the Massachusetts Institute of Technology\, and a Visiting Fellow at Imperial College\, University of London. For several decades he has done international comparative policy studies of public health agencies\, and research on national security policies and environmental policies. He has published on policymaking at the Centers for Disease Control\, the phase-out of CFCs\, toxic substance control\, and innovation in the Air Force. He is currently studying responses to pandemic flu in Europe and the United States\, and the politics of alternative energy projects. He directs a Professional Education summer course at MIT on “Technology\, Innovation and Organizations.” He has also taught in professional education courses for the Royal Society Technology Fellows (London)\, the National University of Singapore\, UC San Diego\, and in Stockholm. Before MIT he was on the research staffs of the School of Public Policy at UC Berkeley\, the Health Policy Center at Brandeis\, and the Harvard School of Public Health. \nEdward You is a Supervisory Special Agent in the FBI’s Weapons of Mass Destruction Directorate\, Biological Countermeasures Unit. Mr. You is responsible for creating programs and activities to coordinate and improve FBI and interagency efforts to identify\, assess\, and respond to biological threats or incidents. These efforts include expanding FBI outreach to the Life Sciences community to address biosecurity. Before being promoted to the Weapons of Mass Destruction Directorate\, Mr. You was a member of the FBI Los Angeles Field Office Joint Terrorism Task Force and served on the FBI Hazardous Evidence Response Team. \nMr. You has also been directly involved in policy-making efforts with a focus on biosecurity. He is an active Working Group member of the National Security Council Interagency Policy Committee on Countering Biological Threats and an Ex Officio member of the NIH National Science Advisory Board for Biosecurity. He also serves on two committees for the National Academies of Sciences\, the Institute of Medicine’s Forum on Microbial Threats and the Committee on Science\, Technology\, and Law’s Forum on Synthetic Biology. \nPrior to joining the FBI\, Mr. You worked for six years in graduate research focusing on retrovirology and human gene therapy at the University of Southern California\, Keck School of Medicine. He subsequently worked for three years at the biotechnology firm AMGEN Inc. in cancer research. \nAndrew Kilianski is currently a GMU professor and biological scientists at the DoD. His work focuses on combating current and future threats from weapons of mass destruction in addition to teaching classes on biosurveillance and virology in the GMU Biodefense graduate program. Dr. Kilianski was previously a National Research Council fellow with the US Army at Edgewood Chemical Biological Center. During his tenure at ECBC\, his research focused on biosurveillance and the identification and characterization of novel agents that threaten today’s warfighter.  Dr. Kilianski’s research interests also included emerging viral pathogens and public health and biodefense policy\, and he was selected as an Emerging Leaders in Biosecurity Initiative Fellow for 2015.  His research has been published in peer-reviewed journals such as PLoS Pathogens\, Journal of Virology\, and Emerging Infectious Diseases while also publishing multiple commentary and op-ed articles.  He received his Ph.D. in Microbiology and Immunology from Loyola University Chicago where his dissertation research involved uncoupling virus-host interactions important for coronavirus pathogenesis and developing antiviral compounds against emerging coronaviruses (SARS-CoV and MERS-CoV). During the workshop\, Dr. Kilianski will be lecturing on biosurveillance and its role as an integral component of any biodefense strategy and how U.S. policy has mandated that such efforts be accelerated. He notes that “. This construct\, and how the US and international entities engage in biosurveillance will be covered\, as well as how recent Ebola and Zika virus outbreaks have tested the system. Emerging technologies and their role in biosurveillance will also be reviewed. Finally\, paths toward integrated biosurveillance for the US and international communities will presented for group discussion discussion.” \nJamechia Hoyle\, DHSc\, MPH\, MS\, PMP is the 2017-2018 Coordinator of the Next Generation Global Health Security Leaders. Dr. Hoyle is a Public Health Consultant and Adjunct Professor at George Mason University\, Fairfax\, VA.  She also instructs preparedness course at the National Center for Biomedical Research and Training\, Baton Rouge\, LA.  Dr. Hoyle has managed multiple public health program activities related to emergency preparedness and response\, operational capacity\, strategic thinking\, response strategies\, and clinical guidance for various Category A\, B\, and C bioterrorism agents.  In addition\, Dr. Hoyle has a strong background in international health\, with a primary focus on project management\, program evaluation\, HIV/AIDS\, sanitation and hygiene and clean water.  Her work has taken her to Liberia\, South Africa\, India\, Haiti\, and Sri Lanka. \nKendall Hoyt is an Assistant Professor at the Geisel School of Medicine at Dartmouth where she studies U.S. biodefense policy\, global health policy\, and biomedical R&D strategy. She is also a lecturer at the Thayer School of Engineering at Dartmouth College where she teaches courses on technology and biosecurity. She is the author of Long Shot: Vaccines for National Defense\, Harvard University Press\, 2012. She currently serves as an advisor to the Coalition for Epidemic Preparedness Innovations (CEPI). CEPI develops vaccines for diseases that have epidemic potential\, such as Lassa\, Nipah\, and MERS. \nKendall Hoyt received her Ph.D. in the History and Social Study of Science and Technology at the Massachusetts Institute of Technology in 2002 and was a Fellow in the International Security Program at the Belfer Center for Science and International Affairs at the Harvard Kennedy School of Government from 2002-2004. Prior to obtaining her degree\, she worked in the International Security and International Affairs division of the White House Office of Science and Technology Policy\, the Washington DC office of McKinsey and Company\, and the Center for the Management of Innovation and Technology at the National University of Singapore. \nFor more biodefense news\, visit the Pandora Report \nPlease contact biodefense@gmu.edu  if you have any additional questions.
URL:https://globalbiodefense.com/event/summer-workshop-on-pandemics-bioterrorism-and-global-health-security-from-anthrax-to-zika/
LOCATION:George Mason University\, Arlington Campus\, Founders Hall\, 3351 Fairfax Drive\, Arlington\, VA\, 22201\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/02/1ff229a13a5c3bcac76d547c7704b0a8.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190630
DTEND;VALUE=DATE:20190701
DTSTAMP:20190619T043333Z
CREATED:20190602T043051Z
LAST-MODIFIED:20190619T043333Z
UID:29329-1561852800-1561939199@globalbiodefense.com
SUMMARY:Estimated Release Date of Draft WHO Roadmap on Neglected Tropical Diseases 2012–2020
DESCRIPTION:At its eleventh meeting in 2018\, the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) recommended that WHO initiate a consultative process with the global NTD community to set new targets and milestones beyond 2020 to achieve the health-related 2030 United Nations Sustainable Development Goals (SDGs). \nPhase 1 feedback was collected\, summarized and presented on 29-30 April 2019 at a STAG-NTD meeting. A second round of feedback from stakeholders will take place following the late June release of the Roadmap draft with the goal of finalizing the Roadmap and milestones by 1 August. \nSource: World Health Organization
URL:https://globalbiodefense.com/event/estimated-release-date-of-draft-who-roadmap-on-neglected-tropical-diseases-2012-2020/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190626
DTEND;VALUE=DATE:20190627
DTSTAMP:20190620T150001Z
CREATED:20190620T150001Z
LAST-MODIFIED:20190620T150001Z
UID:29344-1561507200-1561593599@globalbiodefense.com
SUMMARY:GHSA Supplemental Funding Opportunity Application Deadline - Ebola\, Cholera Outbreak Response
DESCRIPTION:CDC’s Emergency Response and Recovery Branch may have funds available to support emergency activities in response to the Ebola outbreak in the Democratic Republic of the Congo\, the Rohingya refugee crisis in Bangladesh\, and/or global cholera outbreak response. \nIn response to the recent Ebola outbreak in West Africa\, Emergency Response and Recovery Branch (ERRB) has coordinated the establishment of CDC’s Global Rapid Response Team (GRRT). This funding opportunity supports the implementation of programs and activities targeted at increasing the rapid response capacity of CDC’s partners to support populations affected by disease outbreaks\, complex humanitarian emergencies\, armed conflict and other disasters. Its purpose is to decrease the time needed to respond to critical public health emergencies through the provision of logistical mechanisms required for the rapid public health response to humanitarian emergencies and disease outbreaks throughout the world. This effort will expand CDC’s ability to respond quickly and effectively in the event of public health emergencies worldwide. \nAfter a partner organization is initially selected for funding for a specific strategy and activity\, that partner organization may be requested to provide an application for additional strategies and activities through supplemental funding requests and/or a continuation application at the time when CDC solicits the partner organizations for a request for application for emergency funding. Requests to expand strategies and activities are not limited to particular focus areas or countries where the organization was initially selected for funding. It remains at the partner organizations’ discretion to submit an application in response to these supplemental requests or request for applications. \nRead more: Emergency Response and Recovery Supplemental Funding for GHSA Support
URL:https://globalbiodefense.com/event/ghsa-supplemental-funding-opportunity-application-deadline-ebola-cholera-outbreak-response/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190623
DTEND;VALUE=DATE:20190625
DTSTAMP:20190502T003413Z
CREATED:20190416T002610Z
LAST-MODIFIED:20190502T003413Z
UID:27180-1561248000-1561420799@globalbiodefense.com
SUMMARY:CBRN Defense Conference 2019
DESCRIPTION:The NDIA’s 2019 CBRN Defense Conference and Exhibition will be held 23-24 July 2019 in Wilmington\, Delaware. \nHigh-level leadership\, program managers and stakeholders will discuss emerging CBRN threats\, warfighter needs\, science & technology to modernize the future force\, and the outlook for acquisition programs. Industry leaders in the CBRN space will also present on future efforts. \nHighlighted speakers and moderators include: \n\nBG William King\, USA (Ret)\, CWMD Fellow and Executive Advisor\, Booz Allen Hamilton\nDoug Bryce\, Joint Program Executive Officer\, JPEO-CBRND\nMAJ Jay Kopcha\, USA\, NATO Strategic CBRN Staff Officer\, USEUCOM\nLTC Brendan Song\, USA\, J35 CBRNE Officer\, NORTHCOM\nDr. Eric Moore\, Director\, CCDC Chemical Biological Center\nDr. Rick Bright\, Deputy Assistant Secretary\, Preparedness and Response Director\, BARDA\, DHHS\nJames McDonnell\, Assistant Secretary\, CWMD\, DHS\nDr. Jason Roos\, PhD\, Deputy Program Executive Officer\, CBRND\nDr. Ronald Hann\, Director\, R&D (J9) Chem Bio Technologies Department\, DTRA\nMatt Shaw\, Vice President & General Manager\, CBRNE Defense\, Battelle\n\nPlease visit the NDIA’s CBRN Defense 2019 website for more information.
URL:https://globalbiodefense.com/event/cbrn-defense-conference-2019/
LOCATION:Chase Center on the Riverfront\, 815 Justison Street\, Wilmington\, DE\, 19801\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190620
DTEND;VALUE=DATE:20190621
DTSTAMP:20190617T153157Z
CREATED:20190617T153157Z
LAST-MODIFIED:20190617T153157Z
UID:29307-1560988800-1561075199@globalbiodefense.com
SUMMARY:CDC RFI Deadline: Rapid Response to Outbreaks for Sample Collection
DESCRIPTION:CDC is seeking information from companies and other organizations about their capability and capacity to deploy to the site of a domestic or international outbreak or public health emergency\, obtain informed consent\, collect specimens (blood\, urine\, swabs\, etc.) from identified patients\, and safely ship these specimens to CDC in accordance with all applicable local\, state\, and federal and/or international laws\, and regulations. \nAdditionally\, the agency is seeking to obtain information\, needs\, capabilities\, constraints\, capacities\, and requirements of those vendors and companies who do have an interest (or potential interest) in providing the needed services. \nRead more: Collection of Specimens During Outbreak or Public Health Emergency
URL:https://globalbiodefense.com/event/cdc-rfi-deadline-rapid-response-to-outbreaks-for-sample-collection/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190619T140000
DTEND;TZID=America/New_York:20190619T150000
DTSTAMP:20190621T173200Z
CREATED:20190421T173111Z
LAST-MODIFIED:20190621T173200Z
UID:29292-1560952800-1560956400@globalbiodefense.com
SUMMARY:Webinar: Local Health Department Role in Containment of Novel Resistance
DESCRIPTION:As issues with drug resistant pathogens have emerged across the country\, local health departments have been called on to lead and support the containment of novel or targeted multidrug-resistant organisms (MDROs). Join NACCHO to learn more about the experiences of three local health departments who have been affected by containment events. \nBy the end of this webinar\, participants will be able to: \n\nDescribe the experiences of three local health departments supporting containment responses\nIdentify the role of local health departments in containment of MDROs\nDiscuss how other local health departments may prepare for similar events\n\nREGISTER.
URL:https://globalbiodefense.com/event/webinar-local-health-department-role-in-containment-of-novel-resistance/
LOCATION:Webinar
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190617
DTEND;VALUE=DATE:20190620
DTSTAMP:20190414T182823Z
CREATED:20190407T232513Z
LAST-MODIFIED:20190414T182823Z
UID:25885-1560729600-1560988799@globalbiodefense.com
SUMMARY:Biodefense World Summit 2019
DESCRIPTION:Cambridge Healthtech Institute’s (CHI) 5th Annual Biodefense World Summit 2019 is a dynamic conference for the entire biodefense community: technology providers to policy makers at industry\, government and academic institutions. The event will be held on June 17-19\, 2019 at the Hyatt Regency in Bethesda\, MD. \nConferences: \n\nBiodetection Technologies: Biothreat and Pathogen Detection\nBiodetection Technologies: Point-of-Care for Biodefense\nBiosurveillance Integration: Integrated Management of Threats to Public Health and Safety\n\nShort Courses: \n\nSample Prep Technologies for Pathogen Detection\nCommercializing the Next Generation of Biodefense Tools and Technology\n\nHear 50+ strong\, technical presentations & panel discussions by FBI Laboratory\, InDevR Inc.\, Lawrence Livermore National Lab\, Los Alamos National Laboratory\, TetraCore\, Inc.\, U.S. Army Medical Research Institute of Chemical Defense (USAMRICD)\, U.S. Department of Homeland Security\, Walter Reed Army Institute of Research– just to name a few. \nVisit the event website for full details and to register\, or call CHI at +1 781-972-5400. \nFor questions\, email reg@healthtech.com.
URL:https://globalbiodefense.com/event/biodefense-world-summit/
LOCATION:Hyatt Regency Bethesda\, One Bethesda Metro Center\, Bethesda\, MD\, 20814\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/2019-biodefense-world-summit.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190612T140000
DTEND;TZID=America/New_York:20190612T150000
DTSTAMP:20190428T220121Z
CREATED:20190428T215932Z
LAST-MODIFIED:20190428T220121Z
UID:26501-1560348000-1560351600@globalbiodefense.com
SUMMARY:Cross-Sector Collaboration to Implement Health in All Policies (HiAP)
DESCRIPTION:NACCHO is hosting a Health in All Policies (HiAP) webinar series for local health departments. The goal of the webinar series is to provide an open\, informal space for dialogue and peer-to-peer sharing about challenges and best practices. \nThe webinars take place on the second Wednesday of the month\, and each month has a different theme. Each webinar in the series will be recorded and posted to NACCHO’s HiAP webpage; however\, the best way to ensure your questions are answered is to attend the webinar and participate in the discussion. \nWebinar 6: Cross-sector Collaboration to Implement HiAP\nWednesday\, June 12; 2:00-3:00pm ET \nThe webinar will provide an overview of Boston’s Health Equity in All Policies Taskforce and City of Boston departments efforts to apply racial and health equity lens to city programs and services\, with examples from Boston’s sidewalk equity\, public works and transportation equity work. \nRegister now.
URL:https://globalbiodefense.com/event/cross-sector-collaboration-to-implement-health-in-all-policies-hiap/
LOCATION:Online
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190521
DTSTAMP:20190421T201832Z
CREATED:20190421T201149Z
LAST-MODIFIED:20190421T201832Z
UID:26412-1558310400-1558396799@globalbiodefense.com
SUMMARY:RFI Deadline - Malaria Prophylactic Drug Tafenoquine
DESCRIPTION:The U.S. Army Medical Research Acquisition Activity (USAMRAA) located at FT. Detrick\, MD\, has issued a solicitation outlining plans to conduct User Acceptance Testing for the malaria prophylactic drug (Tafenoquine) brand name Arakoda. \nThe operational testing will look at the drug’s performance attributes and usability. \nThe DoD is seeking sources\, capability statements\, and industry feedback for this requirement for one commercial lot of ~120\,000 tablets (7\,500 packages) of Tafenoquine brand name Arakoda immediately\, with base Contract Line Item Number (CLIN) and three optional CLINs to procure up to 3\,750 packages per CLIN. \nEntities interested in submitting a response must furnish in writing\, a 2-3 page (not including cover page\, index or list of references) synopsis of their capability to provide the described product\, including any necessary lead time. \nResponses are due Monday\, 20 May 2019\, 3:00 PM EST. \nRead the full article on the Malaria Drug RFI here.
URL:https://globalbiodefense.com/event/rfi-deadline-malaria-prophylactic-drug-tafenoquine/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/global-biodefense-events-calendar-7.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190517
DTEND;VALUE=DATE:20190518
DTSTAMP:20190513T160228Z
CREATED:20190504T154020Z
LAST-MODIFIED:20190513T160228Z
UID:27240-1558051200-1558137599@globalbiodefense.com
SUMMARY:DARPA ReVector Proposers Day
DESCRIPTION:The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office is holding a Proposers Day meeting on 17 May 2019 to provide information to potential proposers on the objectives of the new ReVector program and to facilitate teaming. \nThe goal of ReVector is to develop an easily delivered treatment — for example\, a topical solution — that safely and temporarily modifies the human skin microbiome to alter scents and thereby reduce attraction of disease-spreading mosquitoes. \nThe Proposers Day will include overview presentations by DARPA personnel and potential government partners; an information session during which government personnel will respond to questions posed by participants; “lightning” talks (three minutes\, one slide) to allow potential proposers to highlight technical capabilities of interest and promote teaming; and short sidebars with DARPA personnel for discussion of any proprietary information that participants would not want to disclose in the other open sessions. \nAttendance at this event is not a requirement for submission of a proposal or selection for funding. Information relayed during the Proposers Day will be made available on the BTO section of the DARPA Opportunities page: http://www.darpa.mil/work-with-us/opportunities. \nDue to space limitations\, attendance is limited to no more than three attendees per division/department unless capacity is not reached. \nParticipants must register in advance through the registration website. You will be required to show government-issued\, picture identification that is compliant with the REAL ID Act of 2005. \nInformation about registration and various other meeting details can be found at the registration website. \nFurther administrative questions should be addressed to DARPA-SN-19-48@darpa.mil. Please refer to the ReVector Proposers Day (DARPA-SN-19-48) in all correspondence. \nDARPA hosts Proposers Days to provide potential performers with information on whether and how they might respond to the Government’s research and development solicitations and to increase efficiency in proposal preparation and evaluation. Therefore\, the ReVector Proposers Day is open only to registered potential applicants\, and not to the media or general public.
URL:https://globalbiodefense.com/event/darpa-revector-proposers-day/
LOCATION:Executive Conference Center (ECC)\, 4075 Wilson Boulevard\, Arlington\, VA\, 22203\, United States
CATEGORIES:Conference,Industry Day
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/05/darpa-bto-revector-proposers-day.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190515T190000
DTEND;TZID=America/New_York:20190515T200000
DTSTAMP:20190501T172329Z
CREATED:20190317T231744Z
LAST-MODIFIED:20190501T172329Z
UID:25407-1557946800-1557950400@globalbiodefense.com
SUMMARY:Emerging Infectious Diseases of Wildlife: A Biosecurity Threat
DESCRIPTION:A ChABSA Technical Seminar will be held in Gaithersburg MD and by webcast on 15 May 2019 on Emerging Infectious Diseases of Wildlife: A Biosecurity Threat. \nSpeaker Bio \nDr. Karen Lips\, Professor of Biology at the University of Maryland is the presenter. She has a B.S. in Zoology from the University of South Florida\, and a Ph.D. in Biology from the University of Miami. She is a field ecologist who studies how global change affects biodiversity. She is interested in how the loss of biodiversity affects communities and ecosystems\, and how human activities contribute to the spread of disease and loss of biodiversity. Dr. Lips was a Jefferson Science Fellow at the Department of State\, where she worked in the Bureau of Western Hemisphere Affairs\, in the Office of Public Diplomacy and Public Affairs\, and where she served as an Embassy Science Fellow in Colombia. Dr. Lips is a Research Associate at the US Museum of Natural History\, an AAAS Leshner Leadership Public Engagement Fellow\, an AAAS Fellow\, an ESA Fellow\, and an Aldo Leopold Leadership Fellow. She was awarded the President’s Award of the Chicago Zoological Society\, a Bay and Paul Biodiversity Leadership Award\, the Sabin Amphibian Conservation Award in 2012\, and the inaugural UMD Impact Communicator Award. Dr. Lips is interested in increasing engagement on environmental issues\, promoting scientific leadership\, and fostering international scientific collaborations.
URL:https://globalbiodefense.com/event/emerging-infectious-diseases-of-wildlife-a-biosecurity-threat/
LOCATION:Medimmune\, One Medimmune Way\, Gaithersburg\, MD\, 20878\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190515
DTEND;VALUE=DATE:20190517
DTSTAMP:20190429T043814Z
CREATED:20190406T012129Z
LAST-MODIFIED:20190429T043814Z
UID:25842-1557878400-1558051199@globalbiodefense.com
SUMMARY:NIAID Small Business Workshop - Los Angeles
DESCRIPTION:The National Institute of Allergy and Infectious Diseases (NIAID) SBIR/STTR Small Business Workshop 2019 will take place 15-16 May 2019 in Los Angeles\, California. \nBiotechnology entrepreneurs\, faculty members\, postdoctoral fellows\, and interested innovators starting a new enterprise can learn about NIH-supported entrepreneurship opportunities\, writing successful grant applications\, and NIH SBIR/STTR policies and regulations. \nThe purpose of this workshop is to prepare current and next-generation biomedical entrepreneurs to compete in NIAID’s (and other Federal) SBIR/STTR programs\, and survey other resources for technology commercialization. Attendees will learn about career opportunities in biomedical entrepreneurship that are supported by the NIH\, receive guidance for preparation of successful grant applications\, and be updated on current NIH SBIR/STTR policies and regulations. We will also discuss SBIR/STTR opportunities for women-owned and socially and economically disadvantaged small businesses. \nThe agenda will include: an overview of the NIH SBIR/STTR programs\, introductions to programs administered by NIAID\, application review\, award management\, Venture Capital and other sources of Investment\, SBIR/STTR grant/proposal writing\, panel discussions\, and one-on-one sessions with NIH Staff.
URL:https://globalbiodefense.com/event/niaid-small-business-workshop-los-angeles/
LOCATION:California NanoSystems Institute at UCLA\, 570 Westwood Plaza\, Los Angeles\, 90095\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190514
DTEND;VALUE=DATE:20190515
DTSTAMP:20190501T171155Z
CREATED:20190407T063506Z
LAST-MODIFIED:20190501T171155Z
UID:25860-1557792000-1557878399@globalbiodefense.com
SUMMARY:3rd Annual NPC Pandemic and Biosecurity Forum
DESCRIPTION:The Scowcroft Institute of International Affairs at the Bush School of Government and Public Service presents the Third Annual Pandemic & Biosecurity Policy Summit on 14 May 2019 at the National Press Club in Washington\, D.C. \nThe discussion will address the 100th anniversary of the 1918-19 influenza outbreak and consider global health security challenges of the 21st Century. \nThis event is designed to foster strategic dialogue with influential thought leaders\, senior U.S. and host country government officials\, and pandemic and biosecurity experts about the growing challenges faced by the international community and policy recommendations for strengthening preparedness and response.
URL:https://globalbiodefense.com/event/3rd-annual-npc-pandemic-and-biosecurity-forum/
LOCATION:National Press Club\, 529 14th Street NW\, Washington\, DC\, 20045\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190508
DTEND;VALUE=DATE:20190512
DTSTAMP:20190501T170200Z
CREATED:20190216T054737Z
LAST-MODIFIED:20190501T170200Z
UID:23606-1557273600-1557619199@globalbiodefense.com
SUMMARY:MAD-ID 2019: Making a Difference in Infectious Diseases
DESCRIPTION:The 22nd Annual MAD-ID Meeting will be held in Orlando\, Florida\, May 8-11\, 2019. \nPharmacists physicians\, nurses and other providers will be given the opportunity to participate in a 3-day educational symposium specifically designed to apply recent research to patient care and antimicrobial stewardship. \nHighlighted sessions include: \n\nThe AMR Challenge: How to Meet the Challenge at Your Institutions\nNew Tests and Technologies for the Microbiology Steward\nPoint of Care Diagnostic Testing\, the Next Frontier for ASPs\nNew Gram-Negative Agents\, Gram-Positive Agents\nOptimizing therapy for Gram-Negative Bacteremia\nShort Course Therapy for Common Infections\nThe Expanding the Antibiotic Pipeline\nBehavior Change Interventions to Improve Outcomes\nPractical Interventions with the Micro Lab\nFormulary Management Strategies in Antimicrobial Stewardship\n\nMAD-ID is an approved provider of continuing pharmacy education and automatically reports to the National Association of Boards of Pharmacy via CPE Monitor.
URL:https://globalbiodefense.com/event/mad-id-2019-making-a-difference-in-infectious-diseases/
LOCATION:Rosen Centre Hotel\, 9840 International Drive\, Orlando\, FL\, 32819\, United States
CATEGORIES:Conference,Continuing Education
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190506
DTEND;VALUE=DATE:20190507
DTSTAMP:20190501T162802Z
CREATED:20190422T050330Z
LAST-MODIFIED:20190501T162802Z
UID:26437-1557100800-1557187199@globalbiodefense.com
SUMMARY:Integration of Opioid and Infectious Disease Prevention Efforts in Select Programs
DESCRIPTION:The National Academies Health and Medicine Division will host a public meeting of the Committee on Examination of the Integration of Opioid and Infectious Disease Prevention Efforts in Select Programs on 7 May 2019. \nThe workshop will take place in Washington D.C. \nThe committee will hear from invited speakers regarding topics pertaining to the statement of task. \nPrimary session topics include: \n\nMulti-site HIV Program with Integrated Opioid Treatment\nComprehensive Treatment of Substance Abuse and Infectious Disease\nIntegration of Hepatitis C Virus Treatment and Substance Abuse Treatment via Telemedicine\nIntegrated Substance Use Treatment and Infectious Disease Treatment Programs (Inpatient / Outpatient)\n\nThe committee was charged with assessing the extent to which opioid and infectious disease prevention programs are integrating the services they provide. The committee will identify and highlight programs that are achieving integration as well as barriers to integration. Conclusions and recommendations from the committee will inform projects that promote patient-centered\, integrated programs to address the opioid and infectious disease epidemics. \nPlease visit the NASEM website for more information.
URL:https://globalbiodefense.com/event/opioid-infectious-disease-prevention-efforts/
LOCATION:National Academy of Sciences\, 2101 Constitution Avenue Northwest\, Washington\, DC\, 20418\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190506
DTEND;VALUE=DATE:20190507
DTSTAMP:20190429T045256Z
CREATED:20190407T023001Z
LAST-MODIFIED:20190429T045256Z
UID:25856-1557100800-1557187199@globalbiodefense.com
SUMMARY:National Network of Libraries of Medicine Wikipedia Edit-a-Thon
DESCRIPTION:The National Network of Libraries of Medicine (NNLM) is continuing its efforts to improve consumer health information on Wikipedia with its third Edit-a-Thon on May 6\, 2019. \nUsing trusted National Library of Medicine resources like PubMed\, MedlinePlus\, and Genetics Home Reference\, NNLM will be working to add citations to existing Wikipedia articles related to health equity. \nCheck out nnlm.gov/wiki to learn more about the event and make sure to follow along on Twitter throughout the day with the hashtag #citeNLM to ask questions\, post photos\, and share your Wikipedia experience. See you on May 6! \nEditor’s note: Please follow their lead and lend your expertise in Infectious Diseases to improve Wikipedia entries.
URL:https://globalbiodefense.com/event/nnlm-spring-2019-wikipedia-edit-a-thon/
LOCATION:Online
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190505
DTEND;VALUE=DATE:20190509
DTSTAMP:20190501T165214Z
CREATED:20190213T173315Z
LAST-MODIFIED:20190501T165214Z
UID:23465-1557014400-1557359999@globalbiodefense.com
SUMMARY:ASM Clinical Virology Symposium 2019
DESCRIPTION:Hear the latest on microbiome-virome interactions\, RNA sequencing for viral diagnosis\, the challenges and opportunities for a universal influenza vaccine\, and more at the 2019 ASM Clinical Virology Symposium\, May 5-8\, 2019. \nWith presentations on the latest research in the field\, you won’t want to miss your chance to hear from top biomedical scientists\, physicians\, and laboratorians about the findings that will shape the future of clinical virology. \nIn addition\, the Pan American Society for Clinical Virology (PASCV) will host the Molecular Virology Workshop\, May 4\, 2019. \nHighlighted topics and presentations include: \n\nOne Health: Challenges of Zoonotic Infections; Jennifer McQuiston; CDC\nHot Topics in Virology; Emily A. Blumberg; Perelman Sch. of Med. at the Univ. of Pennsylvania\nCRISPR-Cas Biology and Infectious Diseases Diagnostic Applications; Daniel S. Chertow; NIH\nDevelopment and Use of Molecular Diagnostic Assays During Recent Ebola and Lassa Fever Outbreaks; Trevor Shoemaker; CDC\nLaboratory Diagnosis of Viral Disease; John Watson; Centers for Disease Control and Prevention\nTest and Treat Diagnostics; Devasena Gnanashanmugam; Cepheid\nEvaluation of Laboratory Contamination during Routine Testing of Infectious Specimens; Melanie Yarbrough; Washington Univ. Sch. of Med.\nA Quick Primer: The Spectrum of Point-of-Care Molecular Tests; Richard Hodinka; Univ. of South Carolina Sch. of Med.\nCirculating EBV and KSHV DNA for Diagnosis and Monitoring; Richard Ambinder; Johns Hopkins Sch. of Med.\nntegration of Point-of-Care Molecular Diagnostics in the Hospital Setting; Frederick Nolte; Med. Univ. of South Carolina\nIs It Time for Point-of-Care Molecular Diagnostics in Pharmacies?; Donald Klepser; Univ. of Nebraska Med. Ctr.\nIntegrative Network Modeling Reveals Host-Pathogen in Alzheimer’s Disease\nHepatitis A Outbreaks on the Rise Across the U.S.; Monique A. Foster; CDC\n\nPlease visit ASM’s Clinical Virology Symposium website for more information
URL:https://globalbiodefense.com/event/2019-asm-clinical-virology-symposium/
LOCATION:Savannah International Trade and Convention Center\, 1 International Drive \, Savannah\, GA\, 31402\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190503
DTEND;VALUE=DATE:20190504
DTSTAMP:20190429T042725Z
CREATED:20190402T041450Z
LAST-MODIFIED:20190429T042725Z
UID:27085-1556841600-1556927999@globalbiodefense.com
SUMMARY:Eureka Prize for Infectious Diseases Research
DESCRIPTION:Entries are being accepted for the Eureka Prize for Infectious Diseases Research through 3 May 2019. \nActivity entered for this prize must have been undertaken in Australia or its territories (as defined by the Australian Government). \nFor a team entry\, the team leader must be either a) an Australian citizen\, b) an Australian permanent resident\, or c) a New Zealand citizen who was resident in Australia\, at the time the research entered was undertaken. \nSponsored by the Australian Infectious Diseases Research Centre\, the $10\,000 prize is awarded to an individual\, group or team for an outstanding recent contribution to infectious diseases research. \nActivity entered for this prize must have been undertaken as a single body of focused infectious diseases research in the past 7 years and have been published in one or more internationally respected scientific journals\, books or equivalent electronic publications. \nPlease visit the Eureka Prize for Infectious Diseases Research website for more information.
URL:https://globalbiodefense.com/event/eureka-prize-for-infectious-diseases-research/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190429
DTEND;VALUE=DATE:20190504
DTSTAMP:20181230T234541Z
CREATED:20180901T204535Z
LAST-MODIFIED:20181230T234541Z
UID:17153-1556496000-1556927999@globalbiodefense.com
SUMMARY:Aberdeen Proving Ground Discovery Week APBI
DESCRIPTION:Save the Date: Team Aberdeen Proving Ground (APG) anticipates hosting the APG Discovery Week Advanced Planning Briefing to Industry (APBI) the week of 29 April-3 May 2019\, at APG\, Maryland. \nAPG is home to more than 70 tenant organizations\, including: \n\nJoint Program Executive Office for Chemical Biological Defense (JPEO-CBD)\nUS Army Research Lab (ARL)\nUS Army Edgewood Chemical Biological Center (ECBC)\n20th Support Command (CBRNE)\nUS Army Test and Evaluation Command (ATEC)\nAberdeen Test Center (ATC)\nUS Army Medical Research Institute of Chemical Defense (USAMRICD)\nUS Army Research\, Development and Engineering Command (RDECOM)\nUS Army Public Health Command (USAPHC)\n\nThe goal of the APG Discovery Week APBI is to provide industry with networking opportunities for both large and small businesses. The APBI will describe potential future contracting opportunities for mission areas that focus on: \n\nCommand\, Control\, Communications\, Computers\, Intelligence\, Surveillance\, and Reconnaissance\nResearch and Development\nTest and Evaluation\nChemical and Biological Defense\nAPG Garrison\n\nThe APG Discovery Week APBI will identify potential contracting opportunities that are aligned with the roadmaps of each respective organization\, specifically focusing on Fiscal Years 2020-2021. Face-to-face breakout sessions between industry attendees and Government contracting representatives are available. \nThe APG Discovery Week APBI will be unclassified and open to all interested contractors\, large and small businesses\, and academia as well as other Government stakeholders. All attendees must be United States citizens. \nSpecific registration procedures and additional information about the APG Discovery Week APBI will be released via amendments on FedBizOps prior to registration opening.
URL:https://globalbiodefense.com/event/aberdeen-proving-ground-discovery-week-apbi/
LOCATION:Aberdeen Proving Ground\, 6000 Combat Drive\, Aberdeen Proving Ground\, MD\, 21005\, United States
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2018/09/aberdeen-proving-ground-discovery-week-2019.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190429
DTEND;VALUE=DATE:20190503
DTSTAMP:20190501T164018Z
CREATED:20190210T235136Z
LAST-MODIFIED:20190501T164018Z
UID:18348-1556496000-1556841599@globalbiodefense.com
SUMMARY:EIS 2019 - CDC Epidemic Intelligence Service Conference
DESCRIPTION:CDC’s 68th annual Epidemic Intelligence Service conference starts April 29. Join CDC disease detectives\, alumni\, and the public health community to learn about leading-edge public health investigations. \nThe annual EIS conference is the nation’s premier epidemiology conference where EIS officers share their work in leading-edge investigations\, scientific findings\, and forward-thinking strategies to inform improvements in public health—all while gaining valuable presentation experience. EIS officers engage in professional networking sessions\, recognition ceremonies and various learning opportunities. \nFree and open to the public\, this conference draws a diverse attention each year from various public health sectors around the world—from epidemiology and laboratory science sleuths and public health organizations to EIS alumni\, news media\, and prospective applicants. \nWhen a killer bacterium unleashes an outbreak on a beach town\, unlikely partners work to find the water source. Hear more about this and other topics in live streamed TED-style talks at the 68th Annual Epidemic Intelligence Service Conference. https://bit.ly/2Geb3CcExternal \nPlease visit the CDC’s Epidemic Intelligence Service Conference for more information.
URL:https://globalbiodefense.com/event/eis-2019-cdc-epidemic-intelligence-service-conference/
LOCATION:Sheraton Atlanta Hotel\, 165 Courtland St NE\, Atlanta\, GA\, 30303\, United States
CATEGORIES:Conference,Continuing Education
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/02/eis-2019-promote-1200x675.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190429
DTEND;VALUE=DATE:20190430
DTSTAMP:20190429T025009Z
CREATED:20190402T024056Z
LAST-MODIFIED:20190429T025009Z
UID:27080-1556496000-1556582399@globalbiodefense.com
SUMMARY:Cedars-Sinai Special Pathogens Symposium 2019
DESCRIPTION:The Cedars-Sinai Special Pathogens Symposium 2019 will be held 29 April 2019 in Los Angeles\, CA. \nHospital preparedness stakeholders from within the region will gather to foster institutional collaboration and education on frontline\, assessment and treatment of high-consequence infectious diseases. \nHighlighted topics include: \n\nGlobal events related to low-incidence\, high-consequence infectious pathogens\nResearch and methods to prevent the spread of novel respiratory pathogens\nRole of the National Ebola Training and Education Center (NETEC) in hospital preparedness\nMethods to strengthen hospital preparedness capacity for emerging respiratory pathogens\nRegional concept of operations regarding transport and management of patients with suspected or confirmed low-incidence\, high-consequence pathogens\nCritical issues relevant for hospital preparedness of emerging respiratory pathogens\nEmerging respiratory pathogens of concern: Focusing on MERS-CoV and Novel Influenza\nEmerging Zoonotic Respiratory Pathogens of Concern\nCommon Challenges in Hospital Readiness for Novel Respiratory Pathogen Preparedness\nUpdates from the Ebola Zaire Outbreak in the Democratic Republic of the Congo\nHospital\, Provincial\, and National Preparedness Efforts Made after the 2003 SARS Outbreak in Toronto\nState Designated Treatment Center Preparedness Efforts\n\nPlease visit the Special Pathogens Symposium 2019 website for more information.
URL:https://globalbiodefense.com/event/cedars-sinai-special-pathogens-symposium-2019/
LOCATION:Harvey Morse Conference Center\, 8700 Gracie Allen Drive\, Los Angeles\, CA\, 90048\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190427
DTEND;VALUE=DATE:20190505
DTSTAMP:20240623T231022Z
CREATED:20190210T010840Z
LAST-MODIFIED:20240623T231022Z
UID:24740-1556323200-1557014399@globalbiodefense.com
SUMMARY:National Infant Immunization Week - NIIW 2019
DESCRIPTION:This year’s annual observation of National Infant Immunization Week is April 27-May 4\, 2019. \nNIIW highlights the importance of protecting infants from vaccine-preventable diseases and to celebrate the achievements of immunization programs and their partners in promoting healthy communities. \nThis is the 25th anniversary of NIIW. Since 1994\, hundreds of communities across the United States have joined to celebrate the critical role vaccination plays in protecting our children\, communities\, and public health. \nSeveral important milestones in controlling vaccine-preventable diseases among infants worldwide worldwide have already been reached: \n\nVaccines have drastically reduced infant death and disability caused by preventable diseases in the U.S.\nThrough immunization\, we can now protect infants and children from 14 vaccine-preventable diseases before age two\nRoutine childhood immunization in one birth cohort prevents an estimated 381 million illnesses\, 24.5 million hospitalizations\, and 855\,000 early deaths over the course of their lifetimes\, at a net savings of $360 billion in direct costs and $1.65 trillion in total societal costs\nThe National Immunization Survey has consistently shown that childhood immunization rates for vaccines routinely recommended for children remain at or near record levels\n\nOne example of the seriousness of vaccine preventable diseases is an increase in measles cases and outbreaks in the United States in recent years. \nNIIW provides an opportunity to: \n\nHighlight the dangers of vaccine-preventable diseases\, especially to infants and young children\, and the importance and benefits of childhood immunization\nEducate parents and caregivers about the importance of vaccination in protecting their children from birth against vaccine-preventable diseases\nFocus attention on immunization achievements and celebrate the accomplishments made possible through successful collaboration\nStep up efforts to protect children against vaccine-preventable diseases and thereby give them a healthy start in life\nEncourage better communication between parents and healthcare professionals.\nRemind parents and caregivers of the importance of making and keeping needed immunization appointments.\nProvide help to parents and caregivers to locate a healthcare professional who participates in the Vaccines for Children’s program\, a federally funded program that provides vaccinations at no cost to children whose parents cannot afford to pay for them.\n\nNIIW is celebrated as part of World Immunization Week (WIW)\, an initiative of the World Health Organization (WHO). During WIW\, all six WHO regions\, including more than 180 Member States\, territories\, and areas\, will simultaneously promote immunization\, advance equity in the use of vaccines and universal access to vaccination services\, and enable cooperation on cross-border immunization activities.
URL:https://globalbiodefense.com/event/national-infant-immunization-week-niiw-2019/
CATEGORIES:Awareness Event
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/02/national-infant-immunization-week-niiw.png
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190409
DTEND;VALUE=DATE:20190412
DTSTAMP:20181224T221905Z
CREATED:20181223T234852Z
LAST-MODIFIED:20181224T221905Z
UID:20619-1554768000-1555027199@globalbiodefense.com
SUMMARY:CBRNe Summit Europe 2019
DESCRIPTION:Intelligence Sec’s annual CBRNe Summit Europe 2019 will be held 9-11 April 2019 in Birmingham\, UK. \nCBRNe threats are becoming a more regular occurrence in major cities across Europe. Many civil and military agencies are now having to improve their response times to major incidents and know on the scene how to quickly resolve the situation. \nCBRNe Summit Europe 2019 will bring together key officials to CBRN capabilities and international cooperation\, the use of robotics within a hotzone\, medical countermeasures to chem-bio attacks\, and first responder techniques\, tactics and procedures. \nHighlighted speakers include: \n\nColonel Carlos Ardanaz\, Commander\, CBRN Regiment\, Spanish Army\nEric Damiens\, Vice President\, Sales and Marketing\, Proengin\nDr. Laura Cochrane\, Director\, Medical and Clinical Affairs\, Emergent BioSolutions\nDr. Pat Mullan\, Principal Scientist\, CBR Division \, DSTL\nDr. Huw Loaring\, Regional Sales Director Europe and Africa\, Detection\, FLIR Systems\nCaptain Bobby Baker\, WMD/HAZMAT Coordinator\, Dallas Fire Rescue\nColonel Wolfgang Reich\, Deputy Director\, NATO Joint CBRN Defence Centre of Excellence\nColonel Denis Josse\, Adviser on CBRN Risks Management & Head of the Pharmaceutical Services\, Alpes-Maritimes Fire and Rescue Services\, France\nLyudmila G. Simeonova\, Head of CBRN Department\, Fire Safety and Civil Protection Chief Directorate\, Ministry of Interior\, Bulgaria\nAllan Cordwell\, Head of Group Emergency Planning\, Resilience & Response Unit\, The Northern Care Alliance NHS Group\, United Kingdom\nLieutenant Colonel Ladislava Navratilova\, Scientist and Chemical Expert\, Fire Rescue Service\, Ministry of Interior\, Czech Republic\nLieutenant Colonel Andrea Dainese\, Course Director\, Protection Department\, NATO School\nChristian Cooper\, Compliance Officer\, National Ambulance Resilience Unit (NARU)\, United Kingdom\nProfessor Robert Chilcott\, Head of Toxicology\, University of Hertfordshire\, United Kingdom\nJon Hall\, Director\, Resilience Advisors\nJaroslav Krasny\, Researcher\, Graduate School for International Development and Cooperation\, Hiroshima University\, Japan\n\nPlease visit the CBRNe Summit Europe 2019 website for more information and to register or contact Intelligence Sec events@intelligence-sec.com or by phone +44 (0)1582 346 706 and we will be happy to provide you further information on how you can participate either as a speaker\, sponsor/exhibitor or as delegates. \nGlobal Biodefense is an official media partner of CBRNe Summit Europe 2019.
URL:https://globalbiodefense.com/event/cbrne-summit-europe-2019/
LOCATION:Jurys Inn Hotel\, 245 Broad Street\, Birmingham\, B1 2HQ\, United Kingdom
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2018/12/2019-cbrne-summit-700x400.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190401
DTEND;VALUE=DATE:20190408
DTSTAMP:20190621T171809Z
CREATED:20190321T171553Z
LAST-MODIFIED:20190621T171809Z
UID:25604-1554076800-1554681599@globalbiodefense.com
SUMMARY:National Public Health Week
DESCRIPTION:During the first full week of April each year\, APHA brings together communities across the United States to observe National Public Health Week as a time to recognize the contributions of public health and highlight issues that are important to improving our nation’s health. This year\, National Public Health Week is on April 1-7\, 2019. \nNPHW 2019 DAILY THEMES\nMonday — Healthy Communities \nTuesday — Violence Prevention \nWednesday — Rural Health \nThursday — Technology and Public Health \nFriday — Climate Change \nSaturday and Sunday — Global Health
URL:https://globalbiodefense.com/event/national-public-health-week/
LOCATION:United States\, United States
CATEGORIES:Awareness Event
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190331
DTEND;VALUE=DATE:20190404
DTSTAMP:20190308T184225Z
CREATED:20190107T215715Z
LAST-MODIFIED:20190308T184225Z
UID:20720-1553990400-1554335999@globalbiodefense.com
SUMMARY:SAFMLS at the CLMA KnowledgeLab 2019
DESCRIPTION:Members of the Society of American Federal Medical Laboratory Scientists (SAFMLS)\, formerly known as the Society of Armed Forces Medical Laboratory Scientists\, will attend the CLMA KnowledgeLab 2019 on March 31 – April 3\, 2019 in Grapevine\, Texas. \nMore than 1\,000 laboratory professionals will gather for a wide variety of general session presentations\, pre-conference workshops and educational breakout sessions available the event. This year’s conference features more education than ever before\, with the opportunity to earn up to 25 CEUs. \nKeynote sessions and workshops include: \n\nClinical Lab 2.0: What is it? How Does This Translate into Laboratory Management and Leadership?\nMHS GENESIS: The New DoD Electronic Health Record\nDLM Exam Preparatory Course\nUsing Data Wisely: Informatics for Laboratory Professionals\nLeadership Essentials: What You Need to Know to Grow\n\nA partial list of participating exhibitors includes: \n\nAbbott Laboratories\nAdvanced Instruments\, Inc.\nAerocom Healthcare\nAmerican Medical Technologists\nAmerican Proficiency Institute\nAMETEK PowerVar\nAUDIT MicroControls\, Inc.\nAureus Medical Group\nBeckman Coulter\, Inc.\nBioFire Defense\nBio-Rad Laboratories\nCAREiQ\nCellaVision\, Inc.\nCleveland Clinic Laboratories\nCLMA\nCollege of American Pathologists\nDenLine Uniforms\, Inc.\nDrucker Diagnostics\nExhibitor Name\nFujirebio U.S.\nGeneral Data Healthcare\, Inc.\nGenesisBPS\nGenial Compliance Systems/Rainbow Scientific\, Inc.\nGFMD\, Ltd.\nGold Standard Diagnostics\nGRIFOLS\nHelmer Scientific\nHemosure\, Inc.\nHenry Schein\, Inc.\nHettich Lab Technology\nInfoMagnetics Technologies Corporation\nInMark Packaging\nInova Diagnostics\nKorchek Technologies\nKurin\, Inc.\nLifePoint Informatics\nLuminex Corporation\nMayo Medical Laboratories\nMedical Courier Elite\nMEDTOX Diagnostics\, Inc.\nOrchard Software Corp.\nOrtho Clinical Diagnostics\nPevco\nRALS Connectivity for POCT\nRees Scientific\nRoche Diagnostics Corporation\nSCC Soft Computer\nSeattle Children’s Hospital – PLUGS Program\nSwisslog Healthcare\nSysmex\nTELCOR\nThe Joint Commission\nThermo Fisher Scientific\nTrinity Biotech\nUniversity of North Dakota School of Medicine\nVanderbilt Pathology Laboratory Services\nVisiun\nWellSky\nWondfo USA Co.\, Ltd.\nWSLH Proficiency Testing\n\nNetwork with colleagues and discover new tactics and technologies for managing your laboratory\, providing high-quality patient care and responding to government regulations and policies. \nPlease visit the CLMA KnowledgeLab 2019 website for more information. \nPlease note: CLMA-SAFMLS Joint Membership is available exclusively to military SAFMLS personnel and includes a yearly membership to both Clinical Laboratory Management Association (CLMA) and the Society of American Federal Medical Laboratory Scientists (SAFMLS). Visit the link for more information.
URL:https://globalbiodefense.com/event/safmls-clma-knowledgelab-2019/
LOCATION:Gaylord Texan Resort\, 1501 Gaylord Trail\, Grapevine\, TX\, 76051\, United States
CATEGORIES:Continuing Education
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/01/2019-safmls-clma-knowledge-lab.png
ORGANIZER;CN="Clinical Laboratory Management Association (CLMA)":MAILTO:info@clma.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190323
DTEND;VALUE=DATE:20190325
DTSTAMP:20190308T183918Z
CREATED:20190204T184615Z
LAST-MODIFIED:20190308T183918Z
UID:24538-1553299200-1553471999@globalbiodefense.com
SUMMARY:From Innovation in Tropical Infectious Diseases to Global Health Solutions
DESCRIPTION:A Gordon Research Seminar (GRS) entitled “From Innovation in Tropical Infectious Diseases to Global Health Solutions” will be held March 23 – 24\, 2019 in Galveston\, Texas. \nThe seminar is a unique forum for junior scientists to receive mentoring\, expand their professional network and exchange cutting-edge ideas on basic and translational bacterial\, viral and parasitic disease research. \nHighlighted presentations include: \n\nComplex Interactions: The Interplay Between Vector\, Pathogen\, Host and the Microbiome\nCRISPR/Cas9 Gene Editing to Block Malaria Transmission\nTranscriptional Plasticity of Leishmania Developmental Stages in the Vector\nPathogen Encoded Evasion of CXCL10 and T-Cell Responses\nThe BITE Study: Defining Human Skin Immunity to Vector Insect Bites\nEffects of Colonization on the Aedes aegypti Microbiome and Vector Competence\nParatransgenic Manipulation of microRNA275 in Tsetse Fly and the Downstream Effect on Trypanosome Infection\n\nPlease visit the From Innovation in Tropical Infectious Diseases to Global Health Solutions website for more information. \nThis GRS will be held in conjunction with the “Tropical Infectious Diseases” Gordon Research Conference (GRC).
URL:https://globalbiodefense.com/event/from-innovation-in-tropical-infectious-diseases-to-global-health-solutions/
LOCATION:Hotel Galvez\, 2024 Seawall Blvd\, Galveston\, 77550\, United States
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/02/2019-innovations-tropical-diseases-global-health-solutions.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190318
DTEND;VALUE=DATE:20190322
DTSTAMP:20190307T224853Z
CREATED:20181223T202727Z
LAST-MODIFIED:20190307T224853Z
UID:20529-1552867200-1553212799@globalbiodefense.com
SUMMARY:NHPC 2019 - National HIV Prevention Conference
DESCRIPTION:The 2019 National HIV Prevention Conference (NHPC) will be held March 18–21\, 2019 in Atlanta\, Georgia. \nThe National HIV Prevention Conference allows in-person collaboration between researchers and program personnel working in HIV prevention. The conference will bring together more than 3\,000 attendees committed to help refine\, improve and strengthen national and local response to HIV. \nThe theme for NHPC 2019 is “Getting to No New HIV Infections\,” which will highlight dynamic approaches to HIV prevention\, detection and management\, and the critical roles that different communities have in achieving this vision. \nThis four-day conference will include plenary sessions along with oral and poster presentations that highlight new HIV science and program activities. \nPlease visit the following links to register to attend the conference\, register to exhibit at the conference\, request space for the CBO/NGO Village\, and request space for an ancillary meeting. \nPlease visit the NHPC website for updates and conference information.
URL:https://globalbiodefense.com/event/nhpc-2019-national-hiv-prevention-conference/
LOCATION:Hyatt Regency Atlanta\, 265 Peachtree street NE\, Atlanta\, 30303\, United States
CATEGORIES:Continuing Education
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2018/12/national-hiv-conference-2019-cdc.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190318
DTEND;VALUE=DATE:20190320
DTSTAMP:20190307T225112Z
CREATED:20181223T215408Z
LAST-MODIFIED:20190307T225112Z
UID:20616-1552867200-1553039999@globalbiodefense.com
SUMMARY:Superbugs & Superdrugs 2019
DESCRIPTION:SMi Group’s Annual Superbugs & Superdrugs conference will take place 18-19 March\, 2019 in London\, UK. \nThis year’s event will gather leaders from pharmaceutical companies\, academia and the wider scientific community together with regulatory agencies and public-private partnerships\, to discuss the growing threat of antibiotic resistance. \nHighlighted session topics and focus areas include: \n\nDevelopment of a pipeline of lysins for infections caused by multidrug-resistant gram-negative bacteria\nAnti-infective research: funding\, filing and finance\nDeveloping target product profiles for priority pathogens\nHow to mobilize private investors for antibiotic drug development\nWellcome Trust: funding opportunities for anti-infective research\nConsiderations for beta-lactams paired with beta-lactamase inhibitors\nA unique combination antibiotic therapy at Helperby\nRidinilazole for the treatment of C. difficile\nDeveloping new therapies for fungal infection\nPharmacodynamics to accelerate antimicrobial drug development for AMR\nOpportunities and challenges involved in pre-clinical development of novel immunotherapies\nEvaluations in prophylaxis and treatment murine models of pneumocystis pneumonia\n\nTo register visit www.superbugssuperdrugs.com/globalbiodefence \nGlobal Biodefense in an official media partner of Superbugs & Superdrugs 2019.
URL:https://globalbiodefense.com/event/superbugs-superdrugs-2019/
LOCATION:Holiday Inn Kensington Forum\, 97 Cromwell Rd\, London\, SW7 4DN\, United Kingdom
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2018/11/superbugs-2019-london.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190315
DTEND;VALUE=DATE:20190317
DTSTAMP:20220906T195421Z
CREATED:20190212T015237Z
LAST-MODIFIED:20220906T195421Z
UID:23485-1552608000-1552780799@globalbiodefense.com
SUMMARY:Mass Gathering Medicine Summit 2019
DESCRIPTION:The fourth annual Mass Gathering Medicine Summit 2019 will be held 15-16 March 2019 in Las Vegas\, Nevada. \nThis annual conference & symposium gathers stakeholders and experts from specialty groups\, hospitals\, major sporting events\, corporate sponsors and music festivals. \nHighlighted sessions include: \n\nDrug Checking: Bridging Public Health and Consumer Safety to Reduce Drug-Related Health Risks at Music Festivals\nPanel: Who “Owns” Event Medicine\nFive Things a Pharmacist Wish You Knew about Event Medicine\nNCState Football’s 2018 Opening Day – Lessons Learned from a 6 Hour MCI\nPsychedelic Emergency Response (PER): Reducing Drug-related Harms at Large Music Festivals\nThe Hindu Pilgrimage: A High-Altitude Mass Gathering\nStop the Bleed: Bleeding Control (BCON) Instructor Course\nImpact of Interprofessional Training on Pediatric Mass Casualty Incident Disaster Preparedness\n\nPlease visit the Mass Gathering Medicine Summit 2019 website for more information.
URL:https://globalbiodefense.com/event/mass-gathering-medicine-summit-2019/
LOCATION:SLS Las Vegas\, a Tribute Portfolio Resort\, 2535 S Las Vegas Blvd\, Las Vegas\, NV\, 89109\, United States
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/02/96deea70656c19c5e2ac38c4f78c7ddd.jpg
ORGANIZER;CN="American Academy of Event Medicine":MAILTO:info@massgatheringmedicine.org
END:VEVENT
END:VCALENDAR